Anne Croy

Alimentiv, Satisfai Health, and Virgo Announce Partnership to use AI-driven technology to Enhance Clinical Trials in IBD and other GI Diseases

Retrieved on: 
Wednesday, October 5, 2022
Physician, HITRUST, Efficiency, Endoscopy, SOC, Inflammatory bowel disease, Intelligence, Patient, Drug development, HIPAA, Biotechnology, Gastroenterology, Research, Private practice, Multimedia, GI, Virgo, Partnership, Technology, Precision medicine, Human, Industry, SOC 2, Eosinophilic esophagitis, CEO, Health, IBD, University, Anne Croy, Artificial intelligence, Clinical trial, Solution, View, CRO, Leadership, Medical imaging, Pharmaceutical industry, Medicine

"This synergy of Satisfai and Virgo with Alimentiv is a positive development for patients with IBD and the drug development space.

Key Points: 
  • "This synergy of Satisfai and Virgo with Alimentiv is a positive development for patients with IBD and the drug development space.
  • Clinical trials have many pain points, and this strategic partnership will enable advances in improving the efficiency of clinical trials and make some significant changes to how trials arerun", said Jeff Smith, CEO of Alimentiv.
  • "We are delighted to enter this arrangement to bring the next generation of imaging technology to clinical trials in gastroenterology."
  • "Working with Virgo, we are excited to bring AI-driven solutions to the IBD clinical trials arena.

Alimentiv, Satisfai Health, and Virgo Announce Partnership to use AI-driven technology to Enhance Clinical Trials in IBD and other GI Diseases

Retrieved on: 
Wednesday, October 5, 2022
Physician, HITRUST, Efficiency, Endoscopy, SOC, Inflammatory bowel disease, Intelligence, Patient, Drug development, HIPAA, Biotechnology, Gastroenterology, Research, Private practice, GI, Virgo, Partnership, Technology, Precision medicine, Human, Industry, SOC 2, Eosinophilic esophagitis, CEO, Health, IBD, Anne Croy, University, Artificial intelligence, Clinical trial, Solution, CRO, Leadership, Medical imaging, Pharmaceutical industry, Medicine

LONDON, ON, Oct. 5, 2022 /PRNewswire/ -- Alimentiv Inc. ("Alimentiv"), Satisfai Health, Inc ("Satisfai"), and Virgo Surgical Video Solutions, Inc. ("Virgo") today announced a strategic partnership to revolutionize central reading, data capture, decision support, and patient recruitment in the clinical trial domain for Inflammatory Bowel Disease (IBD) and allied GI conditions. Satisfai, a global leader in developing artificial intelligence solutions for gastroenterology, and Virgo, an industry leader in endoscopy video capture technology, will leverage their combined strengths to work in partnership with Alimentiv, a leading CRO in gastroenterology, to realize the full potential of AI-powered precision imaging in the GI clinical trials space.

Key Points: 
  • "This synergy of Satisfai and Virgo with Alimentiv is a positive development for patients with IBD and the drug development space.
  • Clinical trials have many pain points, and this strategic partnership will enable advances in improving the efficiency of clinical trials and make some significant changes to how trials arerun", said Jeff Smith, CEO of Alimentiv.
  • "We are delighted to enter this arrangement to bring the next generation of imaging technology to clinical trials in gastroenterology."
  • "Working with Virgo, we are excited to bring AI-driven solutions to the IBD clinical trials arena.